These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 3917348)
1. Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. Beasley R; Smith DA; McHaffie DJ Br Med J (Clin Res Ed); 1985 Jan; 290(6461):9-11. PubMed ID: 3917348 [TBL] [Abstract][Full Text] [Related]
2. Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation. Bøtker HE; Toft P; Klitgaard NA; Simonsen EE Br Heart J; 1991 Jun; 65(6):337-41. PubMed ID: 2054244 [TBL] [Abstract][Full Text] [Related]
3. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation. Pomfret SM; Beasley CR; Challenor V; Holgate ST Clin Sci (Lond); 1988 Apr; 74(4):351-7. PubMed ID: 3281786 [TBL] [Abstract][Full Text] [Related]
4. Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. Molajo AO; Coupe MO; Bennett DH Br Heart J; 1984 Oct; 52(4):392-5. PubMed ID: 6148092 [TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study]. Vitale P; Auricchio A; De Stefano R; Agretto A; De Simone R; Vitale N; Barbato F; Iacono A Cardiologia; 1989 Jan; 34(1):73-81. PubMed ID: 2720716 [TBL] [Abstract][Full Text] [Related]
6. Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels. Maragno I; Santostasi G; Gaion RM; Trento M; Grion AM; Miraglia G; Dalla Volta S Am Heart J; 1988 Aug; 116(2 Pt 1):385-92. PubMed ID: 3400564 [TBL] [Abstract][Full Text] [Related]
7. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation. Lang R; Klein HO; Weiss E; David D; Sareli P; Levy A; Guerrero J; Di Segni E; Kaplinsky E Chest; 1983 Mar; 83(3):491-9. PubMed ID: 6337787 [TBL] [Abstract][Full Text] [Related]
8. [Comparison between digoxin and atenolol in chronic atrial fibrillation]. Lanas F; Salvatici R; Castillo G; Montecinos A; Stockins B; Molina E Rev Med Chil; 1995 Oct; 123(10):1252-62. PubMed ID: 8733316 [TBL] [Abstract][Full Text] [Related]
9. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation. Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273 [TBL] [Abstract][Full Text] [Related]
10. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin. DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872 [TBL] [Abstract][Full Text] [Related]
11. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation. Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation. Lewis RV; McDevitt DG Br J Clin Pharmacol; 1988 May; 25(5):603-6. PubMed ID: 3044426 [TBL] [Abstract][Full Text] [Related]
13. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem. Lewis RV; Irvine N; McDevitt DG Eur Heart J; 1988 Jul; 9(7):777-81. PubMed ID: 3169046 [TBL] [Abstract][Full Text] [Related]
14. Verapamil improves exercise capacity in chronic atrial fibrillation: double-blind crossover study. Lang R; Klein HO; Di Segni E; Gefen J; Sareli P; Libhaber C; David D; Weiss E; Guerrero J; Kaplinsky E Am Heart J; 1983 May; 105(5):820-5. PubMed ID: 6846125 [TBL] [Abstract][Full Text] [Related]
15. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430 [TBL] [Abstract][Full Text] [Related]
16. The beneficial effects of verapamil in chronic atrial fibrillation. Klein HO; Pauzner H; Di Segni E; David D; Kaplinsky E Arch Intern Med; 1979 Jul; 139(7):747-9. PubMed ID: 454060 [TBL] [Abstract][Full Text] [Related]
17. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation. Goldman S; Probst P; Selzer A; Cohn K Am J Cardiol; 1975 May; 35(5):651-5. PubMed ID: 1124719 [TBL] [Abstract][Full Text] [Related]
18. Persistence of digoxin effect in atrial fibrillation. Zener JC; Anggard EE; Harrison DC; Kalman SM JAMA; 1973 Apr; 224(2):239-41. PubMed ID: 4739495 [No Abstract] [Full Text] [Related]
19. Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation. Yahalom J; Klein HO; Kaplinsky E Chest; 1977 May; 71(5):592-6. PubMed ID: 856557 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation. Roth A; Harrison E; Mitani G; Cohen J; Rahimtoola SH; Elkayam U Circulation; 1986 Feb; 73(2):316-24. PubMed ID: 3943166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]